In agreement with the consensus, we found a significant increase in plasma clusterin levels in AD patients, particularly in EOAD; however, this did not translate into good prediction accuracy in ROC analyses (AUC = 0.581 for EOAD, 0.529 for LOAD). Here, CLU is linked to Alzheimer disease.